| b265dd73-73fe-4450-9a2d-496b4ea3850a | 1ad35e44-89a5-42c6-af97-6f4872fc9e33 | 0093069 | DOENCA DE HODGKIN - (ESTADIO I E II) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f1c39717-6a7f-426c-a6ae-d8e42592527d | 64a9ebf0-9d26-4b55-ac6d-b18c76dfc008 | 0093070 | DOENCA DE HODGKIN (ESTADIO III E IV) - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 27a03d3f-bf9c-4c5a-a499-ebd2477e4b48 | 67847f66-d298-4b25-882e-b6b26bfc3345 | 0093071 | DOENCA DE HODGKIN (QUALQUER ESTADIO) - 3A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 411adea5-24fd-4c00-864b-14936d0608a7 | e3407da3-3bf8-4e8a-bb41-a8793ee3896e | 0093072 | DOENCA DE HODGKIN(QUALQUER ESTADIO) - 2ALINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 59c74484-c042-4f9b-ad60-55a4b704ca9d | 2e8290ca-4139-40a6-a208-e6f717f4d381 | 0093073 | DOENCA LINFOPROLIFERATIVA RARA - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fe3c71ec-3c72-4bc2-aa6d-1da889ae7f88 | e9bbc4df-9bf7-43fe-9f1a-e774bfd28b40 | 0093074 | DOENCA LINFOPROLIFERATIVA RARA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 727a77ef-cd7a-4f1b-a8b8-bbf7e7d3d88a | d2cebac9-009c-44db-ba94-05ed0d95a8f0 | 0093075 | DOENCA MIELOPROLIFERATIVA RARA - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bc3633b4-0d9b-468d-811a-75b002bb7eda | 3f79176a-bd9a-499c-950c-297b856ff464 | 0093076 | DOENCA MIELOPROLIFERATIVA RARA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b98147bf-c942-4219-a75b-bbea601703e2 | 24b3b3ad-1832-4d84-8b36-b538510f5825 | 0093077 | F BLASTICA LEUC MIEL CR(COM TRAT ANT 2LINHA) 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 872214e7-3120-450f-a045-b3388b31a5e3 | cdfe5241-9351-4860-b47a-c9b527e6b040 | 0093078 | F BLASTICA LEUC MIEL CR(INCLUI PROFILATICOS) 2 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0774a78f-3d67-45af-8b69-14c0b80598ac | 48d457d8-2aa0-49c5-a6de-6f4e7874179d | 0093079 | F BLASTICA LEUC MIEL CR(SEM TRAT ANT 2LINHA) 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6661a734-a3f6-4d9a-99e5-048aaa1faaab | d452b6b7-e51b-4a59-bc61-1801a0620c40 | 0093080 | F CR LEUC MIEL CR (CONTR SANGUINEO OU CITOGENETICO) 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e639b089-921e-4306-ac30-0f48b2288d7b | 6379f4ee-5701-4704-8b72-53d757e177c0 | 0093081 | F CR LEUC MIELOIDE CR(CONT SANGUINEO) 2 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5a444ec6-6108-488f-ad4b-d57817f60727 | c838f54e-373b-4c37-bb15-17d9babbc62b | 0093082 | F TRANSF LEUC MIEL CR(COM TRAT ANTERIOR 2L) 1LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9216109c-c1cf-4e3c-94e1-03e633f86ba9 | 551f04d2-6d01-46e6-96a4-cd9c9ecd9147 | 0093083 | F TRANSF LEUC MIEL CR(INCL ANTIB PROFIL) 2 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7ef4968e-7087-410c-9a94-011f4f3d077b | 6c2b2b47-82a6-4445-82b3-a10308ee25de | 0093084 | F TRANSF LEUC MIEL CR(SEM TRAT ANTERIOR 2L) 1LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e89a5fdd-1232-4e1c-9205-7a01e4672ec8 | 1974558c-1bd6-48db-8c0f-d248d34443f0 | 0093085 | FASE CRONICA LEUCEMIA MIELOIDE CRONICA (CONTROLE SANGUINEO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b47b020c-de10-4d66-8cb0-227903368a39 | cda29005-3f5c-49ee-a8f4-9bacb1d914c9 | 0093086 | FATOR ESTIMULANTE DO CRESCIMENTO DE COLONIAS DE GRANULOCITOS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2c81dd7c-2468-4c06-9986-fd3da69559fd | fa3904f1-0864-4bff-a911-82c2e50fdf94 | 0093087 | HORMONIOTERAPIA ADJUVANTE À RADIOTERAPIA EXTERNA DO ADENOCARCINOMA DE PRÓSTATA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 86c373f2-25cd-4ed4-85bc-afab1809ef9e | 29012db1-3e6d-4100-b8b9-856532260059 | 0093088 | HORMONIOTERAPIA DE CARCINOMA DE MAMA ESTADIO II | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fef627b8-403a-469c-8767-c8ca396889df | fa5e12bf-4231-4a10-98b1-7d2c453a7e6f | 0093089 | HORMONIOTERAPIA DE CARCINOMA DE MAMA ESTADIO III CLINICO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c3654e28-2005-43ca-9734-95b079a5c0c4 | 86d19982-36ba-425f-8fba-47aee7e17f7c | 0093090 | HORMONIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA AVANÇADO - 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 587241b2-baac-4a50-92c3-8f3da8695890 | 94ccd104-6d21-4c96-bef7-9085c691bbf9 | 0093091 | HORMONIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 4f80713a-bef1-4adc-aff2-354658df106c | f3228feb-b175-44b8-b5b8-c6e2db9205bd | 0093092 | HORMONIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a1fc2faf-a4f4-4829-911c-0203815d26a7 | a376e8a3-bf22-424b-bd4f-eb83b353946b | 0093093 | HORMONIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO- 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fcb78f8b-6511-4eab-9253-19d460aa1c9b | 8a5ec76d-45cb-486a-ad9b-4855577f3cbf | 0093094 | HORMONIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b216104a-e2ac-497c-bbfd-8e6d4a4be565 | <span class="null">NULL</span> | 0093095 | HORMONIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 8fc6b0de-97eb-424f-a86d-03c3143bcc9b | 0f3517f1-4678-4fee-bbb4-5462476f7cb1 | 0093096 | HORMONIOTERAPIA PRÉVIA À RADIOTERAPIA EXTERNA DO ADENOCARCINOMA DE PRÓSTATA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bef39904-201a-4cfa-9523-caa7de5a4e77 | db99bc09-6c39-4f0d-a679-291b6630a265 | 0093097 | IMPLANTAÇÃO DE HALO PARA RADIOCIRURGIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 4d5e4e77-04bd-4667-9c5b-50e4cf943cd8 | <span class="null">NULL</span> | 0093098 | INIBIDOR DA OSTEOLISE | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 20f9a920-4625-4f0b-b0bb-1650c9281b55 | <span class="null">NULL</span> | 0093099 | INTERNAÇÃO P/ RADIOTERAPIA EXTERNA (COBALTOTERAPIA/ACELERADOR) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| aeccda35-1586-423a-b168-89b230685b3c | <span class="null">NULL</span> | 0093100 | IRRADIAÇÃO DE CORPO INTEIRO PRÉ TRANSPLANTANTE DE MEDULA ÓSSEA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c298717f-853f-457d-956e-bb0983a03779 | dab6e7eb-ed08-4dfd-9023-6f63c2c8d19e | 0093101 | IRRADIAÇÃO DE MEIO CORPO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 514bfc3e-8add-4e90-a387-5924e84ee6fc | a090e0a4-5567-46e9-b7ac-f46c668dbe80 | 0093102 | IRRADIAÇÃO DE PELE TOTAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 4b6980c1-ffc1-4188-bff2-79cd584661bd | <span class="null">NULL</span> | 0093103 | LEUCEMIA LINFOCITICA CRONICA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 981e65c0-9fcc-4f6c-a967-587b7a07cb91 | <span class="null">NULL</span> | 0093104 | LEUCEMIA LINFOCITICA CRONICA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5e5cd19d-37ce-4b27-b29e-974a30f7b9ba | 651a0e64-53ef-41fd-a1de-93eadd616c85 | 0093105 | LEUCEMIA PRO-MIELOCITICA AGUDA - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7b5f4298-8bfd-4e6c-9e67-25934436fb50 | 2ce11869-7e04-43f4-8756-cee860899591 | 0093106 | LEUCEMIA PRO-MIELOCITICA AGUDA - FASES SUBSEQUENTES | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| d17f9c68-74a0-4b8e-83b4-145e81292ecc | 5bcf5bc2-e44e-412c-bbd9-94a1ab4e1de0 | 0093107 | LEUCEMIAS AGUDAS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5f4e8c72-801b-4e8f-b531-24c05c018c71 | 72e43002-9932-456f-9ceb-030cf0197217 | 0093108 | LEUCEMIAS AGUDAS (1A RECIDIVA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fdc8807e-f5e8-416c-aef1-4fb7b6321591 | 1bbf826b-55cb-40f2-b94b-9ddcbbc81d84 | 0093109 | LEUCEMIAS AGUDAS (3A RECIDIVA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b3846091-f017-4a9c-9281-39d34c25dbbb | 466013b6-06b3-49f0-88c8-2bad549ed79a | 0093110 | LINFOMA NAO HODGKIN DE BAIXO GRAU DE MALIGNIDADE - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f65f7fea-e8b2-479f-ae13-e0621fa39924 | 4271f2fc-332e-4a1c-8768-1003e3db136f | 0093111 | LINFOMA NAO HODGKIN DE BAIXO GRAU DE MALIGNIDADE - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e2801d58-cc87-4ca7-a852-2cbc95f5c05b | 13f9f44f-68e5-4b97-928f-a697d2410563 | 0093112 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO E | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a2fc236a-db87-4564-9a26-352763f542d2 | <span class="null">NULL</span> | 0093113 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO O | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f50ac97c-cb35-4085-98c5-7591a49b5b21 | 68a07bf2-1d01-4909-b16a-5518183273c2 | 0093114 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO E | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 60e4319d-fa55-4b3e-a031-fb2e66871f02 | 5b821531-8936-4ae4-b8de-8829cca90e60 | 0093115 | MASCARA/IMOBILIZAÇÃO PERSONALIZADA ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a63c4300-821b-4523-9656-98c4087b1a1c | c6a5bc9a-852f-43da-8447-adf149e1fe6e | 0093116 | MELANOMA MALIGNO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9b929097-cf1c-4a94-a54c-ed3a4a5a3798 | dc07324d-5227-4192-bb0a-624cc2c655b7 | 0093117 | METASTASE DE TUMOR PRIMARIO DESCONHECIDO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 640a38ae-9c87-42a3-87c4-f2dc65a4889c | 7356e717-154c-4c6d-8cff-561306902d8c | 0093118 | METASTASE DE TUMOR PRIMARIO DESCONHECIDO (ADENOCARCINOMA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |